Powering a New Wave of Immune Therapeutics
At Sonnet BioTherapeutics, we are taking the fight directly to cancer. Our proprietary FHAB™ (Fully Human Albumin Binding) technology empowers the development of innovative targeted biologic drugs with enhanced single- or bi-specific mechanisms.
About Sonnet BioTherapeutics